Search results (52)
« Back to NewsJoaquim Vieira brings heart regeneration research to the public at Pint of Science
10 May 2022
Pint of Science is the world’s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.
DPAG researchers showcased at premier European Society of Cardiology meeting
5 May 2022
DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.
RDM researchers awarded £2million MRC grant
16 March 2022
Researchers at the Cardiovascular Clinical Research Facility (CCRF) have won a five year MRC funding programme to help understand how high blood pressure (hypertension) during pregnancy affects the heart, brain and blood vessels throughout the life of women, as well as the children born after such a pregnancy.
Study indicates reasons for decline in death rates from heart attacks
7 March 2022
A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.
Commercial development of therapeutic anti-inflammatory peptide begins
15 February 2022
An Oxford BHF CRE “Pump Priming” award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.
Dr Qiang Zhang wins Society for Cardiovascular Magnetic Resonance Early Career Award 2022
8 February 2022
Many congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium
RDM researchers test potential treatment for fatigue in long COVID patients
29 October 2021
The Radcliffe Department of Medicine’s Dr Betty Raman is leading a new a phase 2a clinical trial to investigate whether a drug could treat the fatigue and muscle weakness experienced by many patients who have recovered from COVID.
Drug could help diabetic hearts recover after a heart attack
20 October 2021
New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.
Richard Tyser and Jack Miller honoured by the British Society of Cardiovascular Research
14 September 2021
Dr Richard Tyser is this year’s winner of the Bernard and Joan Marshall Early Career Investigator Prize, and Dr Jack Miller has received a runner-up award, at the British Society of Cardiovascular Research Autumn Meeting.
Reducing fat in the diabetic heart could improve recovery from heart attack
29 July 2021
New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.
High blood sugar levels ‘reprogramme’ stem cells
14 July 2021
Findings explain higher risk of heart attack in people with diabetes, even after treatment .
Critical six-week window to ‘reset’ blood pressure after giving birth
28 June 2021
Home blood pressure monitors could help mothers significantly lower high blood pressure after pregnancy
Iron deficiency anaemia in early pregnancy increases risk of heart defects, suggests new research
8 June 2021
In animal models, iron deficient mothers have a greatly increased risk of having offspring with congenital heart disease (CHD). The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy. Additionally, embryos from a mouse model of Down Syndrome were particularly vulnerable to the effects of maternal iron deficiency, leading to a higher risk of developing severe heart defects.
Genetic breakthrough to target care for deadly heart condition
26 January 2021
Professor Watkins and his team have found a new type of genetic change in the DNA of people with hypertrophic cardiomyopathy (HCM) - a silent killer amongst families that can cause sudden death in young people due to the thickening of the heart muscle.
Earliest origins of the forming heart identified
8 January 2021
The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.
Professor Sir Rory Collins awarded the MRC Millennium Medal 2020
17 December 2020
Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.